510(k) K081104
K081104 is an FDA 510(k) premarket notification submitted by Aesku Diagnostics for the device "AESKULISA ANA HEP-2, REF 30-7115US". The FDA issued a decision of Substantially Equivalent on May 2, 2008. The device falls under product code LKJ (Antinuclear Antibody, Antigen, Control), a Class II device regulated under 21 CFR 866.5100. Aesku Diagnostics has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 2, 2008
- Date Received
- April 18, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Antinuclear Antibody, Antigen, Control
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type